ARMS occur in approximately 20% of RMS patients and is associated with translocations from the fusion of PAX3 or PAX7 with the Forkhead gene FOXO1 resulting in formation of pro-oncogenic gene products [45, 46]. Here, FOXO1 is linked to alveolar rhabdomyosarcoma.